Literature DB >> 18287759

Determining the cellular targets of reactive oxygen species in Borrelia burgdorferi.

Julie A Boylan1, Frank C Gherardini.   

Abstract

The response of Borrelia burgdorferi to the challenge of reactive oxygen species (ROS) is a direct result of its limited biosynthetic capabilities and lack of biologically significant levels of intracellular Fe. In other bacteria, the major target for oxidative damage is DNA as a consequence of the reaction of "free" intracellular with ROS through the Fenton reaction. Therefore, cellular defenses in these bacteria are focused on protecting this essential cellular component. This does not seem to be the case for B. burgdorferi. In this chapter, we describe methods that were used to analyze the potential targets for ROS in B. burgdorferi. Surprisingly, membrane lipids (e.g., linoleic and linolenic acids) derived from host are the major target of ROS in the Lyme disease spirochete.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287759     DOI: 10.1007/978-1-60327-032-8_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  The Synergistic Bactericidal Mechanism of Simultaneous Treatment with a 222-Nanometer Krypton-Chlorine Excilamp and a 254-Nanometer Low-Pressure Mercury Lamp.

Authors:  Jun-Won Kang; Dong-Hyun Kang
Journal:  Appl Environ Microbiol       Date:  2018-12-13       Impact factor: 4.792

2.  The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host.

Authors:  Christian H Eggers; Melissa J Caimano; Robert A Malizia; Toru Kariu; Brian Cusack; Daniel C Desrosiers; Karsten R O Hazlett; Al Claiborne; Utpal Pal; Justin D Radolf
Journal:  Mol Microbiol       Date:  2011-10-12       Impact factor: 3.501

3.  Gene bb0318 Is Critical for the Oxidative Stress Response and Infectivity of Borrelia burgdorferi.

Authors:  Adrienne C Showman; George Aranjuez; Philip P Adams; Mollie W Jewett
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

Review 4.  Lyme Disease Pathogenesis.

Authors:  Jenifer Coburn; Brandon Garcia; Linden T Hu; Mollie W Jewett; Peter Kraiczy; Steven J Norris; Jon Skare
Journal:  Curr Issues Mol Biol       Date:  2020-12-23       Impact factor: 2.081

Review 5.  A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis.

Authors:  Michelle A E Brouwer; Freek R van de Schoor; Hedwig D Vrijmoeth; Mihai G Netea; Leo A B Joosten
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

6.  The Unfolded-Protein Response Triggers the Arthropod Immune Deficiency Pathway.

Authors:  Lindsay C Sidak-Loftis; Kristin L Rosche; Natasha Pence; Jessica K Ujczo; Joanna Hurtado; Elis A Fisk; Alan G Goodman; Susan M Noh; John W Peters; Dana K Shaw
Journal:  mBio       Date:  2022-07-18       Impact factor: 7.786

7.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

8.  Absence of sodA Increases the Levels of Oxidation of Key Metabolic Determinants of Borrelia burgdorferi.

Authors:  Maria D Esteve-Gassent; Trever C Smith; Christina M Small; Derek P Thomas; J Seshu
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

9.  Borrelia burgdorferi elicited-IL-10 suppresses the production of inflammatory mediators, phagocytosis, and expression of co-stimulatory receptors by murine macrophages and/or dendritic cells.

Authors:  Yutein Chung; Nan Zhang; R Mark Wooten
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

10.  Involvement of NADH Oxidase in Biofilm Formation in Streptococcus sanguinis.

Authors:  Xiuchun Ge; Xiaoli Shi; Limei Shi; Jinlin Liu; Victoria Stone; Fanxiang Kong; Todd Kitten; Ping Xu
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.